Running head: ATOPIC DERMATITIS, ITS IMPACT AND TREATMENT
|
|
- Conrad Baker
- 5 years ago
- Views:
Transcription
1 Atopic Dermatitis, Its Impact and Treatment Running head: ATOPIC DERMATITIS, ITS IMPACT AND TREATMENT The Impact of Treatment on Quality of Life of Children with Atopic Dermatitis and their Families Consuela Witherspoon Texas Woman s University
2 Atopic Dermatitis, Its Impact and Treatment 2 The Impact of Treatment on Quality of Life of Children with Atopic Dermatitis and their Families There are so many children living with the misery of atopic dermatitis that it just cannot be overstated for it could have a profoundly negative effect on the health-related quality of life of children and their family unit in so many cases. Giving the prevalence of paediatric atopic dermatitis and its impact on affected children and their families it is surprising that so little attention has been devoted to the impact of treatment on quality of life. Atopic dermatitis, a type of eczema, is the most common skin disease, a potentially debilitating condition in children that can compromise quality of life. It is a chronic inflammatory, itchy skin disease, for which there is no known cure, associated with periods of remission and flare-ups, is frequently a reason for healthcare visits, which adversely affects the quality of life of patients and their families. Its most frequent symptom is pruritus. A vicious cycle is usually created by attempts to relieve the itch by scratching, which simply worsens the rash. It is best described as an episodic disease of exacerbation (flaring) and remission, except in severe cases where it may appear continuous. Ongoing therapy is usually required for many patients having frequent exacerbations. It also represents a substantial health care burden, accounting for approximately 30% of general practice dermatology consultations (McHenry et al, 1995), and 1 in 30 community care consultations (Kerr et al, 2007). Providers must remain mindful of the psychological and qualityof-life burdens imposed on children with atopic dermatitis and their families and tailor treatments to the needs of each individual patient. Atopic dermatitis can pose a great level of difficulty when considering treatment options for this condition, both from the family s perspective and from the view of the practitioners. Treatment should be directed at limiting itching, repairing the skin and decreasing inflammation
3 Atopic Dermatitis, Its Impact and Treatment 3 when necessary. Mainstays of therapy usually consist of lubricants, antihistamines and topical corticosteroids. Despite therapy, some patients do not get total clearance of lesions which often evoke parental concerns. Parents that often express a sense of frustration with treatment plans may often abandon medical therapy. Patients will benefit from efficacious therapy that is customized to meet their individual needs and will thereby experience better disease control, improved satisfaction, and quality of life. Statement of Purpose The purpose of this evidence-based project is to evaluate current literature as it relates to atopic dermatitis, quality of life, treatment, prevention, exacerbations, familial tendencies, and the long-term effects of early intervention. This project will explore the impact of atopic dermatitis on the lives of children and their family units and the use of some of the recently developed treatment measures, which have enabled the physical, psychological and psychological effects of childhood eczema across all aspects of life. This project will further enhance the knowledge of how the effects of an individualized treatment plan have on limiting itching, repairing the skin and decreasing inflammation when necessary. Additionally, this project should posit a guide for nursing interventions and the keys to quality of life that lie in being well-informed, awareness of symptoms, and their possible cause; and developing a partnership involving the patient or caregiver family member, health care provider and other health professionals. Despite the symptoms caused by atopic dermatitis, is this concern regarding the impact of treatment on the quality of life warranted or is it even possible for children with the disorder to maintain a good quality of life?
4 Atopic Dermatitis, Its Impact and Treatment 4 Significance of the Study Incidence and Prevalence Despite its high prevalence, atopic dermatitis has been frequently discounted, regarding it as a minor skin problem that will resolve with time. Although atopic dermatitis is being viewed as a very common inflammatory skin condition in children, it has resulted in many a pediatric healthcare visits. The exact cause of atopic dermatitis continues to be unknown, but familial/genetic factors are considered to play an important role in the development of this disease. The risk of developing atopic dermatitis increases with each first-degree family member suffering from atrophy, and less than half (46%) of patients with atopic dermatitis are known to concomitantly display allergic rhinitis and/or asthma (Raimer, 2000). It affects males as well as females accounting for 10 to 20 percent of all visits to dermatologist offices. Although atopic dermatitis may occur at any age, it most often begins in infancy and childhood. Approximately 70% of cases begin within the first year of life and up to 90% within the first 5 years (Mozaffari et al, Though atopic dermatitis can be reared into adulthood, the adult disease is significantly less than the childhood disorder. According to Mazaffari et al, the lifetime prevalence of atopic dermatitis was reported to be between %, over the last 3 decades. Although it is difficult to identify exactly how many people are affected by atopic dermatitis, an estimated 20 percent of infants and young children experience symptoms of the disease. A universal finding associated with atopic dermatitis is pruritus. Pruritus can be severe, sometimes causing sleep disturbances, irritability and generalized stress for affected patients and family members (Mazaffari et al. 2007). In the majority of cases, pruritus usually causes scratching which results in other skin anomalies such as lichenification (thick accentuation of skin lines), excoriation and breakdown of the skin barrier. Consequently, atopic dermatitis has
5 Atopic Dermatitis, Its Impact and Treatment 5 been referred to as the itch that rashes rather than the rash that itches (Correale et al. 1999). Due to the severity of itching, other associated abnormalities have been reported such as: difficulty falling asleep, diminished total sleep, greater sleep-related awakening, daytime tiredness, and irritability. Health Risk The long term effects are well documented in the literature as the progression from infancy into adulthood occurs. Pediatric atopic dermatitis can affect children s physical abilities, emotions and behavior, social skills, self-esteem, and overall psychological development (Mazaffari et al, 2007). Staphylococcal and streptococcal infections are common complications of atopic dermatitis usually found colonized on the skin of patients with active disease. Occasionally, patients with atopic dermatitis may also develop a herpes simplex infection, characterized by presence of umbilicated vesicles or grouped erosions (Raimer, 2000). Heightened susceptibility occurs because the skin of patients with atopic dermatitis is a poor barrier against organisms. Specific concerns about psychosocial development included fear of future isolation and the development of poor self-esteem. According to the study on social functioning of atopic dermatitis children done by Chamlim et al, twelve of the twenty-three parents and three of the six experts reported that children avoided contact or playing with atopic children, most often for fear of contagion. A feeling of social isolation and staying home more to avoid unwanted and anxiety-producing advice and negative comments from extended family and strangers was described.
6 Atopic Dermatitis, Its Impact and Treatment 6 Research Question Despite the symptoms caused by atopic dermatitis, is this concern regarding the impact of treatment on the quality of life warranted or is it even possible for children with the disorder to maintain a good quality of life? Relevant Articles Relationships between quality of life and disease severity in atopic dermatitis/eczema syndrome during childhood The purpose of this review is to give workers in the field an easy-to-read, up-to-date and accessible summary of recent advances in the relationship between quality of life and disease severity in atopic dermatitis/eczema syndrome during childhood. It has been shown that childhood atopic dermatitis has a major impact on children and families quality of life and disease severity were positively correlated at a point in time and over a period of time. They also showed that children and quality of life measures have improved after medical interference. Despite the limitation of the study reviewed, it is logical to conclude that childhood atopic dermatitis has affected children and families quality of life. However, disease severity and quality of life should be measured independently. Quality of life in atopic dermatitis patients The aim of this study was to evaluate the impact of atopic dermatitis on the quality of life of children or adults and to identify the area of patients lives most affected by the disease. The study agreed with previous findings that atopic dermatitis has a major impact on physical wellbeing. The individuals dealing with atopic dermatitis and their families need more than just the physical treatment of symptoms. Educational and psychological support for patients and their
7 Atopic Dermatitis, Its Impact and Treatment 7 families in addition to medical treatment of atopic dermatitis may improve their long-term physical outcomes. People with atopic dermatitis tend to report lower health-related quality of life and greater psychological distress than the general population. Children with atopic dermatitis often have behavioral problems such as increased dependency, fearfulness, and sleep difficulties. Peer and teacher relations may be affected by atopic dermatitis because of fear of infection, the child s physical appearance, or limitations on sports participation.
8 Atopic Dermatitis, Its Impact and Treatment 8 References Ben-Gashir, M. (2003). Relationship between quality of life and disease severity in atopic dermatitis/eczema syndrome during childhood. Current Opinion in Allergy and Clinical Immunology, 3, Chamlin, S., Frieden, I., Williams, M.L., & Chren, M. (2004). Effects of Atopic Dermatitis on Young American Children and Their Families. Pediatrics, 114 (3), Correale, C., Walker, C., Murphy, L., & Craig, T. (1999). Atopic Dermatitis: A Review of Diagnosis and Treatment. American Family Physician, 60 (4), Kerr, O.A., Benton, E.C., Walker, J.J., Aldridge, R.D., & Tidman, M.J. (2007). Dermatological workload: primary versus secondary care. British Journal of Dermatology, 153(suppl 1): 1-8. McHenry, P.M., Williams, H.C., & Bingham, E.A. (1995). Management of atopic eczema. Joint Workshop of the British Association of Dermatologist and the Research Unit of the Royal College of Physicians of London. British Medical Journal, 310 (6983), Mozaffari et al. (2007). Quality of life in atopic dermatitis patients. Journal of Microbiology, Immunology and Infection, 40, Raimer, S. (2000). Managing Pediatric Atopic Dermatitis. Clinical Pediatrics, 39, 1-14.
9 Atopic Dermatitis, Its Impact and Treatment 9 New Search Menu Item. No Sub Menu Available. Publications Menu Item. No Sub Menu Available. CINAHL Headings Menu Item. No Sub Menu Available. Evidence-Based Care Sheets Menu Item. No Sub Menu Available. More Menu With Sub menus. Sign In to My EBSCOhost Folder New Features! Help Folder has items Folder is empty TEXAS WOMANS UNIV Result List: (MH "Quality of Life") Select one or more databases. Searching: CINAHL Plus with Full Text Choose Databases» Suggest Subject Terms (((MH "Quality of Life")) and (S2)) and (S1) join operator and Select a Field (optional) in Select a Field (optional) in join operator and Select a Field (optional) Add Row in Search Clear Search modes
10 Atopic Dermatitis, Its Impact and Treatment 10 Basic Search Advanced Search Visual Search Search History/Alerts Preferences» Search History/Alerts Print Search History Retrieve Searches Retrieve Alerts Save Searches / Alerts Clear Search History and Add Combine searches with: Add to Search Search Terms Search Options Actions Delete Search ID# S2 S1 (MH "Quality of Life") (MH "Dermatitis, Atopic") Search modes - Boolean/Phrase Search modes - Boolean/Phrase View Results (23433) Revise Search View Details View Results (780) Revise Search View Details X Interface - EBSCOhost Search Screen - Advanced Search Database - CINAHL Plus with Full Text 1: J Microbiol Immunol Infect Jun;40(3): Links Quality of life in atopic dermatitis patients. Mozaffari H, Pourpak Z, Pourseyed S, Farhoodi A, Aghamohammadi A, Movahadi M, Gharaghozloo M, Moin M. Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, IR, Iran. mozafart@sina.tums.ac.ir BACKGROUND AND PURPOSE: Atopic dermatitis (AD) is a common skin condition. The aim of this study was to evaluate the impact of AD on the quality of life of children or
11 Atopic Dermatitis, Its Impact and Treatment 11 adults and to identify the area of patients' lives most affected by the disease. METHODS: Eighty six patients with AD who were referred to an immunology clinic and 98 patients (>4 years old) attending a general clinic acting as controls (without any chronic or severe disease) participated in this survey. A physician filled the Children's Dermatology Life Quality Index (CDLQI) questionnaire for 4-16 year old children and the Dermatology Life Quality Index (DLQI) questionnaire for individuals more than 16 years via face-to-face interview. RESULTS: There were significant differences between the mean of CDLQI score and DLQI score in case and control groups (p<0.001). For children and adults with AD, the mean score of each question was significantly higher than in the control group (p<0.001). CONCLUSIONS: This study agreed with previous findings that AD has a major impact on physical well-being. The individuals dealing with AD and their families need more than just the physical treatment of symptoms. Educational and psychological support for patients and their families in addition to medical treatment of AD may improve their long-term physical outcomes. PMID: [PubMed - indexed for MEDLINE] 1: Curr Opin Allergy Clin Immunol Oct;3(5): Links Relationship between quality of life and disease severity in atopic dermatitis/eczema syndrome during childhood. Ben-Gashir MA. St John's Institute of Dermatology, the Guy's, Kings and St Thomas' School of Medicine, London, UK. mohamed.ben_gashir@kcl.ac.uk PURPOSE OF REVIEW: Atopic dermatitis is a chronic relapsing itchy disease that has an effect on children and families' quality of life. The purpose of this review is to give workers in the field an easy-to-read, up-to-date and accessible summary of recent advances in the relationship between quality of life and disease severity in atopic dermatitis/eczema syndrome during childhood. This review, however, concentrates on original articles that have been published since 1 April 2002, and reports a relationship between disease severity and quality of life scores in childhood atopic dermatitis. RECENT FINDINGS: It has been shown that childhood atopic dermatitis has a major impact on children and families' quality of life. Researchers also reported that scores on quality of life and disease severity were positively correlated at a point in time and over a period of time. They also showed that children and quality of life measures have improved after medical interference. SUMMARY: Despite the limitation of the studies reviewed, it is logical to conclude that childhood atopic dermatitis has affected children and families' quality of life. These studies have also reported that disease severity and
12 Atopic Dermatitis, Its Impact and Treatment 12 quality of life are correlated in childhood atopic dermatitis at a point in time and over time. However, these aspects should be studied further in order to evaluate the longterm impact of the disease and its variation during childhood. Disease severity and quality of life should be measured independently. PMID: [PubMed - indexed for MEDLINE]
Received: June 29, 2006 Revised: August 15, 2006 Accepted: August 30, 2006
Quality J Microbiol of life Immunol in atopic Infect. dermatitis patients 7;4:6-64 Quality of life in atopic dermatitis patients Original Article Habibeh Mozaffari, Zahra Pourpak,, Sara Pourseyed, Abolhasan
More informationECZEMA SOCIETY OF CANADA ATOPIC DERMATITIS: PATIENT INSIGHTS REPORT MILD-TO-MODERATE DISEASE
ECZEMA SOCIETY OF CANADA ATOPIC DERMATITIS: PATIENT INSIGHTS REPORT MILD-TO-MODERATE DISEASE 1 OVERVIEW OF SURVEY RESULTS INTRODUCTION PATIENT INSIGHTS BY THE NUMBERS: Adult Atopic Dermatitis (AD) In the
More informationWhat is atopic dermatitis?
What is atopic dermatitis? Complex inflammatory skin disorder intense pruritus cutaneous hyperreactivity immune dysregulation Chronic with exacerbations and remissions Affects all ages, but more common
More informationAn Everyday Guide to Eczema
An Everyday Guide to Eczema By Dr. Kristel Polder, Board-Certified Dermatologist Developed in Partnership with Who is affected by eczema? 32 million people in the US 1 in 5 children 1 in 12 adults *www.eczema.org
More informationCorrelation between Severity of Atopic Dermatitis and Sleep Quality in Children and Adults
Severity of AD and Sleep Quality pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 28, No. 3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.321 ORIGINAL ARTICLE Correlation between Severity of Atopic Dermatitis
More informationNovan Announces Promising Clinical Results with SB414
Novan Announces Promising Clinical Results with SB414 In the recently completed Phase 1b trial for atopic dermatitis, clinical efficacy measures were highly correlated with critical and disease-relevant
More informationUNDERSTANDING ATOPIC DERMATITIS IN AUSTRALIA
Key points: Australia has a high lifetime prevalence of atopic dermatitis (AD) of around 32%. The country relies on regional Asia-Pacific guidelines for AD, which lack recommendations around the use of
More informationDermatology Literary Review
Emollients and ageing skin: optimising effectiveness and safety of Nursing, Vol. 25, No.11, pages 596-598. 6 Article outlines the causes of dryness in ageing skin and concludes that emollients are the
More informationeczema the basics 2EE6E629CEA25112ABD0B8EB Eczema The Basics 1 / 6
Eczema The Basics 1 / 6 2 / 6 3 / 6 Eczema The Basics Eczema is a group of conditions that cause inflammation of the skin. Typically, eczema causes skin to become itchy, red, and dry -- even cracked and
More informationThe Impact of Hay Fever - a survey by Allergy UK PART 1
The Impact of Hay Fever - a survey by Allergy UK PART 1 Supported and funded by HayMax April 2016 Foreword The role of Allergy UK, is to support the needs and concerns of those with allergies and intolerances.
More informationUNDERSTANDING ATOPIC DERMATITIS IN ITALY
UNDERSTANDING ATOPIC DERMATITIS IN Key points: Around 17% of people in Italy would have atopic dermatitis (AD) at some point in their life known as lifetime prevalence ; the disease is highly prevalent
More informationThe management of chronic urticaria in primary care for adults and children
The management of chronic urticaria in primary care for adults and children September Version 2.0 This supersedes version 1.0 Review due in September 2019 Document location DOCUMENT CONTROL Copies of this
More informationClinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57
Atopic eczema in under 12s: diagnosis and management Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationAllergic Rhinitis: Effects on Quality of Life and Co-morbid Conditions
Disclosures : Effects on Quality of Life and Co-morbid Conditions Nycomed Pharmaceutical Sepracor Pharmaceutical Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine University of Tennessee
More informationClinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57
Atopic eczema in under 12s: diagnosis and management Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57 NICE 2007. All rights reserved. Contents Introduction... 4 Child-centred care...
More informationFood allergies and eczema
Department of Dermatology Food allergies and eczema Information for parents and carers Eczema, also known as atopic eczema or atopic dermatitis, is a skin condition that causes inflammation and irritation.
More informationDermatitis (inflammatory skin condition) Nonallergic. dermatitis. Non-atopic eczema (non- IgE mediated)
Atopic Eczema Dermatitis (inflammatory skin condition) Allergic dermatitis -eczema Nonallergic dermatitis Atopic eczema (IgE mediated) Non-atopic eczema (non- IgE mediated) Pathophysiology of Eczema Allergy
More informationATOPIC ECZEMA. What are the aims of this leaflet?
ATOPIC ECZEMA What are the aims of this leaflet? This leaflet has been written to help you understand more about atopic eczema. It tells you what it is, what causes it, what can be done about it, and where
More information10/9/16. Experiences Build Brain Architecture. Genes and Experiences Work Together. Stress: Understanding its Impact, Symptoms and Recovery
Profectum 6 th Annual NY Conference Stress: Understanding its Impact, Symptoms and Recovery Working From The Inside Out Integrating Medical and Developmental Interventions: A Case Study Presented by: Traci
More informationDupilumab for treating adults with moderate to severe atopic dermatitis [ID1048]
Dupilumab for treating adults with moderate to severe atopic dermatitis [ID1048] Thank you for agreeing to give us your organisation s views on this technology and its possible use in the NHS. You can
More informationSkin prick testing: Guidelines for GPs
INDEX Summary Offered testing but where Allergens precautions are taken Skin prick testing Other concerns Caution Skin testing is not useful in these following conditions When skin testing is uninterpretable
More informationTeledermatology Paediatric eczema. Dr Carolyn Charman Consultant Dermatologist Royal Devon and Exeter Hospital
Teledermatology Paediatric eczema Dr Carolyn Charman Consultant Dermatologist Royal Devon and Exeter Hospital NHS e-referral teledermatology Rapid access to diagnosis / management advice from local integrated
More informationWhat Should General Practice Trainees Learn about Atopic Eczema?
J. Clin. Med. 2015, 4, 360-368; doi:10.3390/jcm4020360 Article OPEN ACCESS Journal of Clinical Medicine ISSN 2077-0383 www.mdpi.com/journal/jcm What Should General Practice Trainees Learn about Atopic
More informationAn Update on Allergic Rhinitis. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital
An Update on Allergic Rhinitis Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital Allergic Rhinitis Common condition with increasing prevalence
More informationEczema: a softer approach
.1 Eczema: a softer approach can water softeners bring relief? .02 Eczema: a softer approach can water softeners bring relief? Product Trial Summary Introduction There have been numerous reports of the
More informationContact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age
Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age Dermatology Department The aim of this leaflet is to give you information about contact allergy
More informationLearning Circle: Jan 26, 2011 Childhood Eczema
Learning Circle: Jan 26, 2011 Childhood Eczema Wingfield Rehmus, MD MPH BC Children s Hospital Clinical Assistant Professor, UBC Department of Paediatrics Associate Member, UBC Department of Dermatology
More informationGuselkumab for treating moderate to severe plaque psoriasis [ID1075]
Guselkumab for treating moderate to severe plaque psoriasis [ID1075] Thank you for agreeing to give us your organisation s views on this technology and its possible use in the NHS. You can provide a unique
More informationAssessing the Current Treatment of Atopic Dermatitis: Unmet Needs
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationNovan Provides Update on SB414 Inflammatory Skin Disease Development Program
Novan Provides Update on SB414 Inflammatory Skin Disease Development Program SB414 Nitric Oxide-Releasing Cream Safe and Well-Tolerated in Psoriasis Phase 1b Trial Preclinical Data with SB414 Targeting
More informationThe Role of Allergy Testing to Achieve Personalized Treatment Goals for Allergic Rhinitis and Asthma
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationQuality of Life and Disease Severity Are Correlated in Patients with Atopic Dermatitis
ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology http://dx.doi.org/10.3346/jkms.2012.27.11.1327 J Korean Med Sci 2012; 27: 13271332 Quality of Life and Disease Severity Are Correlated in
More informationTechnology appraisal guidance Published: 25 August 2004 nice.org.uk/guidance/ta82
Tacrolimus and pimecrolimus for atopic eczema Technology appraisal guidance Published: 25 August 2004 nice.org.uk/guidance/ta82 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationIn 2002, it was reported that 72 of 1000
REPORTS Aligning Patient Care and Asthma Treatment Guidelines Eric Cannon, PharmD Abstract This article describes how the National Asthma Education and Prevention Program Guidelines for the Diagnosis and
More informationEVALUATION OF THERAPEUTIC PROGRAMS EDUCATING AD PATIENTS AND THEIR PARENTS
EVALUATION OF THERAPEUTIC PROGRAMS EDUCATING AD PATIENTS AND THEIR PARENTS Rencontres 2èmes Internationales sur l Él Éducation Thérapeutique dans la Dermatite Atopique Rome, le 1er juillet 2011 Danielle
More informationManagement of Senile Atopic Dermatitis in Geriatric Outpatient Clinic Dermatovenereology Department Ciptomangunkusumo Hospital in
Global Journal of Medical Research: F Diseases Volume 18 Issue 2 Version 1.0 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Online ISSN: 2249-4618 & Print ISSN:
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationPatient Questionnaire Chronic Urticaria
Patient Questionnaire Chronic Urticaria (Baseline) Dear Patient, Your answers to the following questions regarding the present situation of your Chronic Urticaria and its course up to now can help to better
More informationPaediatric Food Allergy. Introduction to the Causes and Management
Paediatric Food Allergy Introduction to the Causes and Management Allergic Reactions in Children Prevalence of atopic disorders in urbanized societies has increased significantly over the past several
More informationAllergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children
The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient s health, mood and
More informationMarch 9, 2015 From: The Pediatric Dermatology Research Alliance (PeDRA)
Web: www.pedraresearch.org From: The Pediatric Dermatology Research Alliance (PeDRA) To: Jennifer Shepherd, Center for Drug Evaluation and Research Food and Drug Administration, 10903 New Hampshire Ave.,
More informationBrodalumab for treating moderate to severe plaque psoriasis [ID878]
Brodalumab for treating moderate to severe plaque psoriasis [ID878] Thank you for agreeing to give us your organisation s views on this technology and its possible use in the NHS. You can provide a unique
More informationExpert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report 2007
Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report 2007 TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS Selecting Initial Therapy
More informationAtopic Dermatitis in Tuen Mun Skin Clinic
ORIGINAL ARTICLES Atopic Dermatitis in Tuen Mun Skin Clinic A survey of patient's characteristics, severity, prognosis and the family impact Dr. N. M. Luk Social Hygiene Service (Dermatology), Department
More informationBAPSI Score Report Page 1 of 8 BAPSI
BAPSI Score Report Page 1 of 8 BAPSI Behavioral Assessment of Pain Screening Instrument Patient: Prince Charming SSN: 667-90-8876 Date of Birth: 01/01/1930 Sex: male Date Tested: 08/03/2012 Reviewed by:
More information15 minute eczema consultation
THERAPY WORKSHOP 15 minute eczema consultation History Current treatments Examination Treatment Plan Written action plan Soap substitute/bath oil Antiseptic baths Emollients Topical steroids Other treatments
More informationImproving Your Sleep Course. Session 1 Understanding Sleep and Assessing Your Difficulties
Improving Your Sleep Course Session 1 Understanding Sleep and Assessing Your Difficulties Course Information Session Details Sessions Session 1 Session 2 Session 3 Session 4 Optional Review Session 5 Session
More informationTopical Doxepin Prior Authorization with Quantity Limit Program Summary
Topical Doxepin Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1-3 Agent(s) Indication(s) Dosage & Administration Doxepin 5% cream Prudoxin (doxepin) cream 5% KS_PS_Topical_Doxepin_PAQL_ProgSum_AR1018
More informationCHAPTER 1. Eczema Basics
CHAPTER 1 Eczema Basics Definition Eczema is an inflammatory skin condition, characterised by ichtyosis (dry skin), erythema (redness), excoriation (interruption of the skin), scratching lesions, lichenification
More informationHAE disease fact sheet
[Insert organization logo and the hae day :-) logo] HAE disease fact sheet Hereditary Angioedema (HAE) is a rare, potentially life threatening inherited disorder with symptoms of severe, painful, and recurring
More informationClinical Study Report SLO-AD-1 Final Version DATE: 09 December 2013
1. Clinical Study Report RANDOMIZED, OPEN, PARALLEL GROUP, PHASE IIIB STUDY ON THE EVALUATION OF EFFICACY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY IN PAEDIATRIC PATIENTS WITH ATOPIC DERMATITIS, WITH OR WITHOUT
More informationChange/Insert Date & Location via >Insert >Header & Footer To view drawing guides
Patient profiling Who is your patient and what do they want to hear? What are your patient s ideas, concerns, expectations (ICE)? How much do they already know about their psoriasis? Is your patient more
More informationExpert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report 2007
Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report 2007 TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS Selecting Initial Therapy
More informationPUBLIC SUMMARY OF RISK MANAGEMENT PLAN (RMP) Elidel 10mg/g cream DATE: , VERSION 12.0
PUBLIC SUMMARY OF RISK MANAGEMENT PLAN (RMP) Elidel 10mg/g cream DATE: 23.11.2016, VERSION 12.0 VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Eczema mainly affects children
More informationSleep and mental wellbeing: exploring the links
Sleep and mental wellbeing: exploring the links Like most physiological functions, the length and quality of sleep is influenced by a host of biological, environmental and lifestyle factors. Across all
More informationOnline Data Supplement Primary Ciliary Dyskinesia: First Health-related Quality of Life Measures for Pediatric Patients
Online Data Supplement Primary Ciliary Dyskinesia: First Health-related Quality of Life Measures for Pediatric Patients Sharon D Dell, Margaret W. Leigh, Jane S Lucas, Thomas W. Ferkol, Michael R. Knowles,
More informationIf looking for a book Psoriasis Cure: Treatments, Natural Remedies and Best Home Managements (Skin Disease, Skin Problems, Skin Diseases and
Psoriasis Cure: Treatments, Natural Remedies And Best Home Managements (Skin Disease, Skin Problems, Skin Diseases And Disorders Book 1) By Jeff Kennedy READ ONLINE If looking for a book Psoriasis Cure:
More informationConcussions: Treatment and Impact to Learning
Concussions: Treatment and Impact to Learning School Nurse Update August 19 and 20, 2015 Andrea Dorsch, Ph.D. Pediatric Neuropsychology Pediatric Psychology and Psychiatry Services Oh, you just got your
More informationINSOMNIAS. Stephan Eisenschenk, MD Department of Neurology
INSOMNIAS INSOMNIAS General criteria for insomnia A. Repeated difficulty with sleep initiation, duration, consolidation or quality. B. Adequate sleep opportunity, persistent sleep difficulty and associated
More informationDoes rhinitis. lead to asthma? Does sneezing lead to wheezing? What allergic patients should know about the link between allergic rhinitis and asthma
Does rhinitis lead to asthma? Does sneezing lead to wheezing? What allergic patients should know about the link between allergic rhinitis and asthma For a better management of allergies in Europe Allergy
More informationSkin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist
Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist I have no conflicts of interest 6 yo boy referred for AD. On topical HC and food elimination diet s/p topical triamcinolone to body
More informationUNDERSTANDING ATOPIC DERMATITIS IN THE US
Key points: Resources for training general practitioners to treat atopic dermatitis (AD) remain sparse and inconsistent. A lack of comprehensive data makes it difficult to assess the prevalence of AD in
More informationATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS. Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine
ATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine THE PLAN Is it atopic dermatitis? What is atopic dermatitis? Guidelines
More informationThe proposal is to add text/statements in red and to delete text/statements with strikethrough: POLICY
Omalizumab DESCRIPTION Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody which selectively binds to immunoglobulin E (IgE). High serum levels of IgE are found in individuals with
More informationxx Xolair 150 MG SOLR (GENENTECH)
Omalizumab NDC CODE(S) 50242-0040-xx Xolair 150 MG SOLR (GENENTECH) DESCRIPTION Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody which selectively binds to immunoglobulin E (IgE).
More informationNational Asthma Educator Certification Board Detailed Content Outline
I. THE ASTHMA CONDITION 9 20 1 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationHealth-related Quality of Life in Children with Moderate to Severe Atopic Dermatitis
2015;23(3):178-184 CLINICAL ARTICLE Health-related Quality of Life in Children with Moderate to Severe Atopic Dermatitis Milena Ražnatović Djurović 1, Janko Janković 2, Vesna Tomić Spirić 3, Slavenka Janković
More informationReview Process. Introduction. Reference materials. InterQual Specialty Referral Criteria
InterQual Specialty Referral Criteria Review Process Introduction As part of the InterQual Care Planning family of products, InterQual Specialty Referral Criteria provide healthcare organizations with
More informationUK Inflammatory Bowel Disease Audit. A summary report on the quality of healthcare provided to people with inflammatory bowel disease
UK Inflammatory Bowel Disease Audit A summary report on the quality of healthcare provided to people with inflammatory bowel disease Section heading UK IBD Audit summary report 2014 This summary report
More informationHealth Psychology Service for young people with haemophilia and other bleeding disorders
Health Psychology Service for young people with haemophilia and other bleeding disorders This leaflet provides you with information about our service, how we can help you and how to contact us. What is
More informationTony Gray Head of Safety and Security. Tony Gray Head of Safety and Security. Contents Section Description Page No.
Health and Safety Policy Practice Guidance Note Latex Sensitivity V04 Date Issued Planned Review Issue 1 Oct 17 Oct 2020 HS-PGN-10 Part of NTW(O)20 Health and Safety Policy Author/Designation Tony Gray
More informationEvolution of asthma from childhood. Carlos Nunes Center of Allergy and Immunology of Algarve, PT
Evolution of asthma from childhood Carlos Nunes Center of Allergy and Immunology of Algarve, PT allergy@mail.telepac.pt Questionnaire data Symptoms occurring once or several times at follow-up (wheeze,
More informationAYPH conference Young peoples experiences of skin conditions Tess McPherson Consultant dermatologist Oxford
Skin, Stigma, Services & Support AYPH conference Young peoples experiences of skin conditions Tess McPherson Consultant dermatologist Oxford Skin Skin problems major problem in young people Skin condition
More informationJournal of Nobel Medical College
ISSN: 2091-2331 (PRINT) 2091-234X (ONLINE) Journal of Nobel Medical College Available Online: www.nepjol.info, www.nobelmedicalcollege.com.np Volume 7, Number 1, Issue 12, January-June 2018, 45-49 Original
More informationTARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS
TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS Recommendation PULMONARY FUNCTION TESTING (SPIROMETRY) Conditional: The Expert Panel that spirometry measurements FEV1,
More informationMinimum Competencies for Asthma Care in Schools: School Nurse
Minimum Competencies for Asthma Care in Schools: School Nurse Area I. Pathophysiology 1. Explain using simple language and appropriate educational aids the following concepts: a. Normal lung anatomy and
More informationEczema. By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University
Eczema By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University Dermatitis= Eczema =Spongiosis Eczema Atopic Seborrheic Contact Allergic Irritant Nummular Asteatotic Stasis Neurodermatitis/Lichen Simplex
More informationAtopic Dermatitis. Atopic dermatitis (AD) is very common with a. Going Skin Deep With. Carl s rashes
Focus on CME at Dalhousie University Going Skin Deep With Atopic Dermatitis Scott Murray, MD, FRCP(C), BSc Atopic dermatitis (AD) is very common with a tendency for itching and inflammation of the skin.
More informationSteroid use in managing your child s Atopic Eczema
Steroid use in managing your child s Atopic Eczema Clinical Nurse Specialist for Paediatric Dermatology (01284) 713575 Step up step down approach: Addressograph Severe Call your General Practitioner (GP)
More informationIoana Agache Transylvania University Brasov. Precision medicine in allergy and asthma
Ioana Agache Transylvania University Brasov Precision medicine in allergy and asthma Precision medicine and precision health Personalized care based on molecular, immunologic and functional endotyping
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationPublic Dissemination
1. THE ASTHMA CONDITION 9 18 3 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationA llergic disorders are common and represent an important
Thorax tx38844 Module 1 11/8/06 15:15:19 Topics: 196 Thorax Online First, published on September 1, 2006 as 10.1136/thx.2004.038844 1 EPIDEMIOLOGY Time trends in allergic disorders in the UK R Gupta, A
More informationA critical appraisal of: Canadian guideline fysisk aktivitet using the AGREE II Instrument
A critical appraisal of: Canadian guideline fysisk aktivitet using the AGREE II Instrument Created with the AGREE II Online Guideline Appraisal Tool. No endorsement of the content of this document by the
More informationQuality of life in children with psoriasis
Quality of life in children with psoriasis Marieke Seyger Psychodermatologie: het kind centraal Vrijdag 23 januari 2015 AMC Amsterdam Disclosure Has received research grants from / was involved in clinical
More informationA llergic disorders are common and represent an important
91 REVIEW Time trends in allergic disorders in the UK R Gupta, A Sheikh, D P Strachan, H R Anderson... See end of article for authors affiliations... Correspondence to: Ms R Gupta, Division of Community
More informationApproach to eczema. Hugo Van Bever Department of Pediatrics NUHS - Singapore
Approach to eczema Hugo Van Bever Department of Pediatrics NUHS - Singapore APAPARI workshop, Yangon, October 30, 2016 Eczema in children 1. Atopic dermatitis 2. Constitutional eczema 3. Contact dermatitis
More informationUNDERSTANDING DEPRESSION Young Adult: Get the Facts
UNDERSTANDING DEPRESSION Young Adult: Get the Facts What does it mean when a heath care professional says depression? Hearing a health care professional say you have depression can be confusing. The good
More informationRecurrent Wheezing in Preschool Children. William Sheehan, MD Associate Professor of Pediatrics Division of Allergy and Immunology
Recurrent Wheezing in Preschool Children William Sheehan, MD Associate Professor of Pediatrics Division of Allergy and Immunology Disclosure I have nothing to disclose related to this talk. Background
More informationDupilumab and Crisaborole for Atopic Dermatitis: Effectiveness, Value, and Value-Based Price Benchmarks
Dupilumab and Crisaborole for Atopic Dermatitis: Effectiveness, Value, and Value-Based Price Benchmarks Draft Background and Scope November 7, 2016 Background: Atopic dermatitis (eczema) is a chronic/chronically-relapsing
More informationparts induction and development of self consciousness, defense mechanisms, unavoidable
2. LITERATURE REVIEW A study investigating the symptomatology of abnormal appearance using written accounts of 54 patients with various facial abnormalities revealed a similar pattern which can be divided
More informationCBT in the Treatment of Persistent Insomnia in Patients with Cancer
CBT in the Treatment of Persistent Insomnia in Patients with Cancer Colin A Espie University of Glasgow Sleep Centre Sackler Institute of Psychobiological Research University of Glasgow Scotland UK Outline
More informationAuthor s response to reviews
Author s response to reviews Title: The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study Authors:
More informationALLERGIES ARE OUT THERE.
ALLERGIES ARE OUT THERE. DID YOU KNOW THAT DOGS AND CATS CAN HAVE ALLERGIES TOO? Some people are affected by allergies and experience itching or other symptoms that cause discomfort. Our dogs and cats
More informationXYZAL 5 MG FILM-COATED TABLET
XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,
More informationBJD British Journal of Dermatology. Summary. What s already known about this topic? CONCISE COMMUNICATION
CONCISE COMMUNICATION BJD British Journal of Dermatology Self-administration of hospital-based narrowband ultraviolet B (TL-01) phototherapy: a feasibility study in an outpatient setting S. Yule, S. Sanyal,
More informationQuality Of Life and its Associated Factors among Children with Atopic Eczema in Kelantan, Malaysia
1816 Quality Of Life and its Associated Factors among Children with Atopic Eczema in Kelantan, Malaysia Ahmad Abir Ab. Ghani 1, Norhayati Mohd. Noor 1*, Rosediani Muhamad 1, Zulrusydi Ismail 2 1 Department
More informationREFERENCE CODE GDHC296DFR PUBLICATION DATE NOVEMBER 2013 DUPILUMAB (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC296DFR PUBLICATION DATE NOVEMBER 2013 DUPILUMAB (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Dupilumab in the nine major pharmaceutical markets
More information